Lv1
34 积分 2024-12-02 加入
PD-1/PD-L1免疫检查点抑制剂治疗不同BRAF基因型晚期结直肠癌的临床效果与安全性
2个月前
已完结
不同类型BRAF突变对结直肠癌生物学及免疫微环境的调控和机制研究
2个月前
已完结
TILs相关因子与PD-L1在dMMR/MSI-H型结直肠癌中的表达及临床意义
2个月前
已完结
POU2F3: A Sensitive and Specific Diagnostic Marker for Neuroendocrine-low/negative Small Cell Lung Cancer
2个月前
已完结
Molecular and Immunohistochemical Classification of Extrapulmonary Small Cell Neuroendocrine Carcinomas: A Study of 181 Cases
3个月前
已完结
[Advances in constitutional mismatch repair deficiency syndrome associated tumors]
9个月前
已完结
[Application of PMS2 and MSH6 double-antibody detection in screening of mismatch repair deficient tumors]
9个月前
已完结
皖公网安备34019202002308
